Glaxosmithkline Plc Adr Stock Probability of Future Stock Price Finishing Over 41.05

GSK Stock  USD 43.13  0.14  0.33%   
GlaxoSmithKline PLC's implied volatility is one of the determining factors in the pricing options written on GlaxoSmithKline PLC ADR. Implied volatility approximates the future value of GlaxoSmithKline PLC based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in GlaxoSmithKline PLC ADR over a specific time period. For example, 2024-03-28 CALL at $43.0 is a CALL option contract on GlaxoSmithKline PLC's common stock with a strick price of 43.0 expiring on 2024-03-28. The contract was last traded on 2024-03-27 at 15:59:18 for $0.17 and, as of today, has 0 days remaining before the expiration. The option is currently trading at a bid price of $0.15, and an ask price of $0.2. The implied volatility as of the 28th of March is 19.53. View All GlaxoSmithKline options

Closest to current price GlaxoSmithKline long CALL Option Payoff at Expiration

GlaxoSmithKline PLC's future price is the expected price of GlaxoSmithKline PLC instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of GlaxoSmithKline PLC ADR performance during a given time horizon utilizing its historical volatility. Check out GlaxoSmithKline PLC Backtesting, GlaxoSmithKline PLC Valuation, GlaxoSmithKline PLC Correlation, GlaxoSmithKline PLC Hype Analysis, GlaxoSmithKline PLC Volatility, GlaxoSmithKline PLC History as well as GlaxoSmithKline PLC Performance.
  
At this time, GlaxoSmithKline PLC's Price Fair Value is quite stable compared to the past year. Please specify GlaxoSmithKline PLC's target price for which you would like GlaxoSmithKline PLC odds to be computed.

GlaxoSmithKline PLC Target Price Odds to finish over 41.05

The tendency of GlaxoSmithKline Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 41.05  in 90 days
 43.13 90 days 41.05 
about 41.04
Based on a normal probability distribution, the odds of GlaxoSmithKline PLC to stay above $ 41.05  in 90 days from now is about 41.04 (This GlaxoSmithKline PLC ADR probability density function shows the probability of GlaxoSmithKline Stock to fall within a particular range of prices over 90 days) . Probability of GlaxoSmithKline PLC ADR price to stay between $ 41.05  and its current price of $43.13 at the end of the 90-day period is about 30.49 .
Considering the 90-day investment horizon GlaxoSmithKline PLC has a beta of 0.14. This usually indicates as returns on the market go up, GlaxoSmithKline PLC average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding GlaxoSmithKline PLC ADR will be expected to be much smaller as well. Additionally GlaxoSmithKline PLC ADR has an alpha of 0.227, implying that it can generate a 0.23 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   GlaxoSmithKline PLC Price Density   
       Price  

Predictive Modules for GlaxoSmithKline PLC

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as GlaxoSmithKline PLC ADR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GlaxoSmithKline PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
41.9842.9743.96
Details
Intrinsic
Valuation
LowRealHigh
38.6944.3445.33
Details
Naive
Forecast
LowNextHigh
42.6343.6244.61
Details
8 Analysts
Consensus
LowTargetHigh
36.0639.6343.99
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as GlaxoSmithKline PLC. Your research has to be compared to or analyzed against GlaxoSmithKline PLC's peers to derive any actionable benefits. When done correctly, GlaxoSmithKline PLC's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in GlaxoSmithKline PLC ADR.

GlaxoSmithKline PLC Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. GlaxoSmithKline PLC is not an exception. The market had few large corrections towards the GlaxoSmithKline PLC's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold GlaxoSmithKline PLC ADR, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of GlaxoSmithKline PLC within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
0.23
β
Beta against NYSE Composite0.14
σ
Overall volatility
2.03
Ir
Information ratio 0.13

GlaxoSmithKline PLC Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of GlaxoSmithKline PLC for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for GlaxoSmithKline PLC ADR can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Latest headline from zacks.com: Heres Why GSK Gained But Lagged the Market Today

GlaxoSmithKline PLC Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of GlaxoSmithKline Stock often depends not only on the future outlook of the current and potential GlaxoSmithKline PLC's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. GlaxoSmithKline PLC's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding4.1 B
Cash And Short Term Investments5.2 B

GlaxoSmithKline PLC Technical Analysis

GlaxoSmithKline PLC's future price can be derived by breaking down and analyzing its technical indicators over time. GlaxoSmithKline Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of GlaxoSmithKline PLC ADR. In general, you should focus on analyzing GlaxoSmithKline Stock price patterns and their correlations with different microeconomic environments and drivers.

GlaxoSmithKline PLC Predictive Forecast Models

GlaxoSmithKline PLC's time-series forecasting models is one of many GlaxoSmithKline PLC's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary GlaxoSmithKline PLC's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about GlaxoSmithKline PLC ADR

Checking the ongoing alerts about GlaxoSmithKline PLC for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for GlaxoSmithKline PLC ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Latest headline from zacks.com: Heres Why GSK Gained But Lagged the Market Today
When determining whether GlaxoSmithKline PLC ADR is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlaxoSmithKline Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glaxosmithkline Plc Adr Stock. Highlighted below are key reports to facilitate an investment decision about Glaxosmithkline Plc Adr Stock:

Complementary Tools for GlaxoSmithKline Stock analysis

When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is GlaxoSmithKline PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Dividend Share
0.58
Earnings Share
3.02
Revenue Per Share
14.97
Quarterly Revenue Growth
0.092
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.